ODI Pharmavor 52 Minuten2 Min.Preliminary results for ODI Pharma indicate significant revenue increase in Q3 2023/2024ODI Pharma AB (“ODI” or the “Company”) announces today that the preliminary financial results for the third quarter of fiscal year...
ODI Pharma6. Dez. 20233 Min.ODI Pharma AB announces sale of the skincare brand kandol. for 3.2 msekODI Pharma AB (“ODI” or the “Company”) announces today the sale of the skincare brand kandol. to Niclas Kappelin. The transaction, valued...
ODI Pharma7. Aug. 20233 Min.ODI Pharma AB enters into exclusive collaboration with Synoptis Pharma Sp. z o.o.ODI Pharma AB (“ODI” or “the Company”) hereby announces that the Company has entered through its Polish subsidiary into a collaboration...
ODI Pharma1. Juni 20232 Min.ODI Pharma AB receives loan financing of EUR 350,000ODI Pharma AB (“ODI” or “the Company”) hereby announces that the Company has secured loan financing of EUR 350,000 from an external...